• Home
  • News
  • Analysis
  •  
    Regions
    • Australasia
    • Southeast Asia
    • Greater China
    • North Asia
    • South Asia
    • North America
    • Europe
    • Central Asia
    • MENA
  •  
    Funds
    • LPs
    • Buyout
    • Growth
    • Venture
    • Renminbi
    • Secondary
    • Credit/Special Situations
    • Infrastructure
    • Real Estate
  •  
    Investments
    • Buyout
    • Growth
    • Early stage
    • PIPE
    • Credit
  •  
    Exits
    • IPO
    • Open market
    • Trade sale
    • Buyback
  •  
    Sectors
    • Consumer
    • Financials
    • Healthcare
    • Industrials
    • Infrastructure
    • Media
    • Technology
    • Real Estate
  • Events
  • Chinese edition
  • Data & Research
  • Weekly Digest
  • Newsletters
  • Sign in
  • Events
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)870 240 8859

      Email: customerservices@incisivemedia.com

      • Sign in
     
      • Saved articles
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • RSS
    • Twitter
    • LinkedIn
    • Newsletters
  • Free Trial
  • Subscribe
  • Weekly Digest
  • Chinese edition
  • Data & Research
    • Latest Data & Research
      2023-china-216x305
      Regional Reports

      The reports review the year's local private equity and venture capital activity and are filled with up-to-date data and intelligence on fundraising, investments, exits and M&A. The regional reports also feature information on key companies.

      Read more
      2016-pevc-cover
      Industry Review

      Asian Private Equity and Venture Capital Review provides an independent overview of the private equity, venture capital and M&A activities in the Asia region. It delivers insights on investments made, capital raised, sector specific figures and more.

      Read more
      AVCJ Database

      AVCJ Database is the ultimate link between Asian dealmakers and those who provide advisory, financial, legal and technological services to the private equity, venture capital and M&A industries. It is packed with facts and figures on more than 153,000 companies and almost 117,000 transactions.

      Read more
AVCJ
AVCJ
  • Home
  • News
  • Analysis
  • Regions
  • Funds
  • Investments
  • Exits
  • Sectors
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)870 240 8859

    Email: customerservices@incisivemedia.com

    • Sign in
 
    • Saved articles
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 

China

Advent acquires China restaurant operator
Advent acquires China restaurant operator

Advent International has acquired a 60% stake in health food restaurant chain Wagas Group from its founders.

  • Greater China
  • 22 September 2022
Weekly digest - September 21 2022
Weekly digest - September 21 2022

  • Region
  • 21 September 2022
China semiconductor: Casualties of war
China semiconductor: Casualties of war

Private equity investment in China’s semiconductor industry continues unabated despite intensifying US regulatory action. While start-ups are not explicitly targeted, many are feeling the heat

  • Greater China
  • 21 September 2022
China drug developer Worg secures $57m Series B
China drug developer Worg secures $57m Series B

Worg, a China-based drug developer, has closed a Series B round of CNY400m (USD57m) from five local investors - Jiachen Capital, Longpan Capital, Kaitai Capital, Puhua Capital and Anji Ruixing Capital.

  • Greater China
  • 20 September 2022
GenBridge, DragonBall back China snacks brand Xueji Chaohuo

GenBridge Capital and DragonBall Capital have led a CNY 600m (USD 86m) Series A round for Xueji Chaohuo, a China-based roasted seeds and nuts brand.

  • Greater China
  • 20 September 2022
EQT exits China packaging business to OTPP

EQT has confirmed the sale of its co-control stake in China-headquartered packaging manufacturing company GPA Global to Ontario Teachers’ Pension Plan Board (OTPP) for an undisclosed sum.

  • Greater China
  • 20 September 2022
China satellite player Galaxy Space achieves unicorn status
China satellite player Galaxy Space achieves unicorn status

Galaxy Space, a China-based satellite developer, has raised a new funding round led by CCB International at a post-investment valuation of CNY 11bn (USD 1.6bn).

  • Greater China
  • 19 September 2022
China's HighLight hits first close on life sciences fund, targets $650m
China's HighLight hits first close on life sciences fund, targets $650m

HighLight Capital, a China-based life sciences investor, has completed a first close of USD 540m on its fourth US dollar-denominated fund. The overall target is USD 650m.

  • Greater China
  • 16 September 2022
China looks to boost PE participation by domestic insurers
China looks to boost PE participation by domestic insurers

Chinese Premier Li Keqiang has asked regulators to encourage investment by insurance companies in private equity and venture capital through measures such as shorter post-IPO lock-up periods.

  • Greater China
  • 15 September 2022
Weekly digest - September 14 2022
Weekly digest - September 14 2022

  • Region
  • 14 September 2022
L'Oréal China investment unit backs local fragrance brand
L'Oréal China investment unit backs local fragrance brand

L'Oréal has completed the debut deal from its newly formed China investment arm by participating in an extended Series A round for local fragrance brand Documents.

  • Greater China
  • 14 September 2022
Deal focus: L'Oréal shows staying power
Deal focus: L'Oréal shows staying power

Europe-based personal care giant L’Oréal looked past short-term impediments like lockdowns and asset price corrections to join Cathay Capital in supporting Chinese perfume brand Documents

  • Greater China
  • 13 September 2022
TPG-backed Dingdang Health raises $51m in Hong Kong IPO
TPG-backed Dingdang Health raises $51m in Hong Kong IPO

Chinese online pharmacy platform Dingdang Health has raised HKD 402.4m (USD 51m) through a Hong Kong IPO, defying challenging conditions for financial sponsors targeting the bourse.

  • Greater China
  • 13 September 2022
China AI player Fourth Paradigm files for Hong Kong IPO
China AI player Fourth Paradigm files for Hong Kong IPO

Fourth Paradigm, a China-based software provider that helps enterprise customers develop in-house artificial intelligence (AI) decision-making applications, has filed for a Hong Kong IPO.

  • Greater China
  • 09 September 2022
China fitness app Keep pursues Hong Kong listing
China fitness app Keep pursues Hong Kong listing

Keep, a China-focused fitness app operator backed by the likes of GGV Capital, SoftBank Vision Fund 2, and 5Y Capital, has filed for a Hong Kong IPO.

  • Greater China
  • 08 September 2022
Weekly digest - September 07 2022
Weekly digest - September 07 2022

  • Region
  • 07 September 2022
China circuit board maker JLC raises $129m
China circuit board maker JLC raises $129m

Chinese circuit board manufacturing company Jialichuang (JLC) has raised CNY 900m (USD 129m) from State Development & Investment Corporation (SDIC), Eastern Bell Capital and Jianfa Xinxing Investment.

  • Greater China
  • 07 September 2022
Deal focus: Turning data into operational efficiencies
Deal focus: Turning data into operational efficiencies

Chinese data mining start-up Prothentic has managed to turn first-time business into repeat subscription business, which led to valuation increase between funding rounds even as the wider market stagnates

  • Greater China
  • 07 September 2022
China drug developer BoomRay gets $43m
China drug developer BoomRay gets $43m

Chinese drug developer BoomRay Pharmaceuticals has raised a CNY300m (USD 43m) Series A round led by Sequoia Capital China.

  • Greater China
  • 07 September 2022
China's Welkin Capital targets London IPO
China's Welkin Capital targets London IPO

China-focused Welkin Capital is looking to raise up to USD 300m through an IPO for a London-listed investment entity seeded with assets from its debut private equity fund, which closed in 2017.

  • Greater China
  • 06 September 2022
China cell therapy developer Neukio raises $50m
China cell therapy developer Neukio raises $50m

Shanghai-based cell therapy developer Neukio Biotherapeutics has raised USD 50m in the first tranche of a Series A round led by medical technology-focused CD Capital. Other new investors include Alwin Capital and Surplus Capital.

  • Greater China
  • 06 September 2022
China EV player Leapmotor targets Hong Kong IPO
China EV player Leapmotor targets Hong Kong IPO

LeapMotor has filed for an IPO in Hong Kong, putting it on course to become the fourth of China's "new force" electric vehicle (EV) manufacturers to go public.

  • Greater China
  • 05 September 2022
China chip designer Yige raises $42m angel round
China chip designer Yige raises $42m angel round

Suzhou Yige Technology, a China-based semiconductor chip designer also known as EagleChip, has raised a CNY 286m (USD 41.5m) angel round led by Matrix Partners China, Redpoint China, Sequoia Capital China, CTC Capital, and Vlight Capital.

  • Greater China
  • 01 September 2022
Weekly digest - August 31 2022
Weekly digest - August 31 2022

  • Region
  • 31 August 2022
192021
  • About AVCJ
  • Advertise
  • Contacts
  • About ION Analytics
  • Terms of use
  • Privacy policy
  • Group disclaimer
  • RSS
  • Twitter
  • LinkedIn
  • Newsletters

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013